{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,6,14]],"date-time":"2023-06-14T09:40:30Z","timestamp":1686735630974},"reference-count":23,"publisher":"Oxford University Press (OUP)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,4,1]]},"DOI":"10.1093\/cid\/cir1041","type":"journal-article","created":{"date-parts":[[2012,2,5]],"date-time":"2012-02-05T02:00:15Z","timestamp":1328407215000},"page":"1010-1012","source":"Crossref","is-referenced-by-count":0,"title":["Yet Another Reason to Treat HIV Infection"],"prefix":"10.1093","volume":"54","author":[{"given":"Thor A.","family":"Wagner","sequence":"first","affiliation":[{"name":"Seattle Children\u2019s Research Institute and University of Washington, Seattle"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisa M.","family":"Frenkel","sequence":"additional","affiliation":[{"name":"Seattle Children\u2019s Research Institute and University of Washington, Seattle"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2012,2,4]]},"reference":[{"key":"2019091011314222900_bib1","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1097\/QAI.0b013e3181b9869f","article-title":"Declines in mortality rates and changes in causes of death in HIV-1-infected children during the HAART era","volume":"53","author":"Brady","year":"2010","journal-title":"J Acquir Immune Defic Syndr"},{"key":"2019091011314222900_bib2","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1056\/NEJMoa0800971","article-title":"Early antiretroviral therapy and mortality among HIV-infected infants","volume":"359","author":"Violari","year":"2008","journal-title":"N Engl J Med"},{"key":"2019091011314222900_bib3","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1067\/mpd.2002.125007","article-title":"Effect of combination antiretroviral therapy on cerebrospinal fluid HIV RNA, HIV resistance, and clinical manifestations of encephalopathy","volume":"141","author":"McCoig","year":"2002","journal-title":"J Pediatr"},{"key":"2019091011314222900_bib4","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1097\/QAD.0b013e32832dc041","article-title":"Impact of HAART and CNS-penetrating antiretroviral regimens on HIV encephalopathy among perinatally infected children and adolescents","volume":"23","author":"Patel","year":"2009","journal-title":"AIDS"},{"key":"2019091011314222900_bib5","volume-title":"Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents","year":"2011"},{"key":"2019091011314222900_bib6","volume-title":"Antiretroviral therapy of HIV infection in infants and children: towards universal access: recommendations for a public health approach\u20142010 revision","year":"2010"},{"key":"2019091011314222900_bib7","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/j.jaci.2003.07.003","article-title":"Lymphocyte subsets in healthy children from birth through 18 years of age: the Pediatric AIDS Clinical Trials Group P1009 study","volume":"112","author":"Shearer","year":"2003","journal-title":"J Allergy Clin Immunol"},{"key":"2019091011314222900_bib8","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.jaci.2009.10.010","article-title":"Lymphocyte subsets in healthy Malawians: implications for immunologic assessment of HIV infection in Africa","volume":"125","author":"Mandala","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"2019091011314222900_bib9","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1093\/cid\/cir1037","article-title":"Neurocognitive and motor deficits in HIV-infected Ugandan children with high CD4 cell counts","volume":"54","author":"Ruel","year":"2012","journal-title":"Clin Infect Dis"},{"key":"2019091011314222900_bib10","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1212\/WNL.41.6.778","article-title":"Nomenclature and research case definitions for neurologic manifestations of human immunodeficiency virus-type 1 (HIV-1) infection: report of a Working Group of the American Academy of Neurology AIDS Task Force","volume":"41","year":"1991","journal-title":"Neurology"},{"key":"2019091011314222900_bib11","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.jpeds.2004.10.021","article-title":"Incidence and prevalence of HIV encephalopathy in children with HIV infection receiving highly active anti-retroviral therapy (HAART)","volume":"146","author":"Chiriboga","year":"2005","journal-title":"J Pediatr"},{"key":"2019091011314222900_bib12","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1212\/01.WNL.0000287431.88658.8b","article-title":"Updated research nosology for HIV-associated neurocognitive disorders","volume":"69","author":"Antinori","year":"2007","journal-title":"Neurology"},{"key":"2019091011314222900_bib13","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1097\/QAD.0b013e328340fd42","article-title":"Editorial neuroAIDS review","volume":"25","author":"Shapshak","year":"2011","journal-title":"AIDS"},{"key":"2019091011314222900_bib14","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1177\/135965350501000607","article-title":"Cerebrospinal fluid HIV-1 infection usually responds well to antiretroviral treatment","volume":"10","author":"Mellgren","year":"2005","journal-title":"Antivir Ther (Lond)"},{"key":"2019091011314222900_bib15","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1097\/QAD.0b013e32832c4152","article-title":"Impact of combination antiretroviral therapy on cerebrospinal fluid HIV RNA and neurocognitive performance","volume":"23","author":"Marra","year":"2009","journal-title":"AIDS"},{"key":"2019091011314222900_bib16","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1086\/657342","article-title":"HIV-1 viral escape in cerebrospinal fluid of subjects on suppressive antiretroviral treatment","volume":"202","author":"Ed\u00e9n","year":"2010","journal-title":"J Infect Dis"},{"key":"2019091011314222900_bib17","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1097\/00126334-200405010-00003","article-title":"Highly active antiretroviral therapy improves neurocognitive functioning","volume":"36","author":"Robertson","year":"2004","journal-title":"J Acquir Immune Defic Syndr"},{"key":"2019091011314222900_bib18","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1002\/ana.21225","article-title":"Changes in the incidence and predictors of human immunodeficiency virus-associated dementia in the era of highly active antiretroviral therapy","volume":"63","author":"Bhaskaran","year":"2008","journal-title":"Ann Neurol"},{"key":"2019091011314222900_bib19","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1097\/QAD.0b013e3283427da7","article-title":"Persistence of HIV-associated cognitive impairment, inflammation, and neuronal injury in era of highly active antiretroviral treatment","volume":"25","author":"Harezlak","year":"2011","journal-title":"AIDS"},{"key":"2019091011314222900_bib20","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1097\/QAD.0b013e32828e4e27","article-title":"The prevalence and incidence of neurocognitive impairment in the HAART era","volume":"21","author":"Robertson","year":"2007","journal-title":"AIDS"},{"key":"2019091011314222900_bib21","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1097\/QAD.0b013e32834171f8","article-title":"Effects of central nervous system antiretroviral penetration on cognitive functioning in the ALLRT cohort","volume":"25","author":"Smurzynski","year":"2011","journal-title":"AIDS"},{"key":"2019091011314222900_bib22","doi-asserted-by":"crossref","first-page":"9625","DOI":"10.1128\/JVI.79.15.9625-9634.2005","article-title":"Evidence that low-level viremias during effective highly active antiretroviral therapy result from two processes: expression of archival virus and replication of virus","volume":"79","author":"Tobin","year":"2005","journal-title":"J Virol"},{"key":"2019091011314222900_bib23","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1742-6405-2-6","article-title":"Cerebrospinal fluid signs of neuronal damage after antiretroviral treatment interruption in HIV-1 infection","volume":"2","author":"Gissl\u00e9n","year":"2005","journal-title":"AIDS Res Ther"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/cid\/article-pdf\/54\/7\/1010\/29578972\/cir1041.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,14]],"date-time":"2023-06-14T09:22:32Z","timestamp":1686734552000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article\/54\/7\/1010\/297838"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,2,4]]},"references-count":23,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2012,2,4]]},"published-print":{"date-parts":[[2012,4,1]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/cir1041","relation":{},"ISSN":["1537-6591","1058-4838"],"issn-type":[{"value":"1537-6591","type":"electronic"},{"value":"1058-4838","type":"print"}],"subject":[],"published-other":{"date-parts":[[2012,4,1]]},"published":{"date-parts":[[2012,2,4]]}}}